Overview
Read this article from a comprehensive knowledge base, updated and supplemented with articles reviewed by scientific committees.
Read the articleAUTHOR
-
Michel BAUER: Director, International Analysis Department - Sanofi-Synthélabo
INTRODUCTION
After a brief historical review, this first article examines in detail the various definitions concerning crystalline polymorphism and the amorphous state, as well as those concerning powder particles (habitus/facies, aggregation and agglomeration states). Crystalline polymorphism and facies are the consequence of a complex process known as crystallization, for which a brief introduction is given in the case of the crystallization of a molecule from a solvent. This highlights the various physico-chemical parameters that play a key role in this phenomenon (nucleation, activation energy of nucleation, role of solvent and impurities, etc.). Finally, in the last paragraph, a reminder of the elements of crystallography (crystal systems/Bravais lattices, crystal lattice, asymmetric unit) is given, with the aim of establishing a number of definitions necessary for the overall understanding of the three articles that make up this study.
The aim of these articles is to describe this phenomenon and consider its consequences, mainly in the pharmaceutical field, but also in other, less well-known fields. They will appear in the following order:-
[AF 3 640] - Crystallization and polymorphism. Description of the phenomenon;
- - Crystallization and polymorphism. Physical chemistry of polymorphism;
- - Crystallization and polymorphism. Pharmaceutical and other applications.
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Crystallization and polymorphism
Article included in this offer
"Physics and chemistry"
(
198 articles
)
Updated and enriched with articles validated by our scientific committees
A set of exclusive tools to complement the resources
References
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!